Another study by Aguirre et al. in Argentina evaluated both AChR antibody titers and C5a and C3a; although there was a correlation between C5a levels and increased myasthenia gravis composite (MGC) scores, there was no significant difference between controls and MG patients [45]. This evidence concerns the gene C3 and myasthenia gravis.